Lotus Resources Limited Upsizes Capital Raise to Fund Kayelekera Uranium Project Restart

Oct 24, 2024

Highlights:

  • Upsized Placement: Lotus Resources Limited (ASX: LOT) successfully raised AU$130 million (US$87 million) through a two-tranche placement, increasing the initial target of AU$110 million due to strong investor demand.
  • Funding Project Restart: The funds will support the accelerated restart of the Kayelekera Uranium Project in Malawi, positioning Lotus as a key player in the global uranium market by Q3 2025.
  • Share Purchase Plan: Alongside the placement, the company plans a Share Purchase Plan (SPP) aiming to raise up to AU$15 million, allowing eligible shareholders to participate at the same price of AU$0.25 per share.

AU$130 Million Placement to Accelerate Uranium Production

Lotus Resources Limited (ASX: LOT) has successfully completed the bookbuild for a non-underwritten two-tranche placement, raising AU$130 million (US$87 million) before costs at AU$0.25 per share. The funds will be used to accelerate the restart of the company's Kayelekera Uranium Project in Malawi, positioning Lotus as a key uranium producer by Q3 2025.

Strong Demand Leads to Upsized Placement

Initially targeting AU$110 million, Lotus increased the size of the placement to AU$130 million due to overwhelming demand from both existing and new institutional investors. The placement aims to support capital investments and working capital needed for the project's restart, solidifying Lotus' future in the uranium market.

At the time of writing, Lotus shares are expected to resume trading on the ASX today, 24 October 2024. The first tranche of the placement, amounting to AU$66.9 million, will settle on 28 October 2024, with shares trading on 29 October 2024. The second tranche, expected to raise AU$63.1 million, will be subject to shareholder approval at a meeting in early December 2024.

Share Purchase Plan to Raise Additional Funds

In addition to the placement, Lotus will offer a Share Purchase Plan (SPP) targeting to raise up to AU$15 million at the same price of AU$0.25 per share, allowing eligible shareholders to participate on the same terms as institutional investors.

CEO Greg Bittar expressed gratitude for investor support, stating, "The SPP offers existing shareholders the chance to join us in advancing the Kayelekera Uranium Project and becoming a global uranium producer by 2025."

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com